OBJECTIVE: Questionnaires for adequate assessment of the urinary function of neurological patients are not available in Portuguese. The Qualiveen, developed in France for evaluation of general and urinary-related impact on QoL, has been successfully used in neurological patients. AIM: To translate the Qualiveen, to adapt it crossculturally, and to validate it for Portuguese. METHODS: Fifty-one patients with spinal cord injury (SCI), multiple sclerosis (MS), and myelomeningocele (MMC) completed both Qualiveen and the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) twice, at an mean interval of 15.5 days. RESULTS: A reliability study revealed internal consistency (Cronbach's alpha coefficients 0.75-0.90 for all four domains). Test-retest reliability demonstrated moderate to strong stability (intraclass correlation coefficient range from 0.62 to 0.86). Construct validity was assessed using the Qualiveen's scores and ICIQ-SF final score. It was significant for the majority of Qualiveen's score domains compared with the ICIQ-SF final score. CONCLUSION: The Portuguese version of the Qualiveen was successfully adapted and validated. It can be used for evaluation of general and urinary QoL in neurological patients.
OBJECTIVE: Questionnaires for adequate assessment of the urinary function of neurological patients are not available in Portuguese. The Qualiveen, developed in France for evaluation of general and urinary-related impact on QoL, has been successfully used in neurological patients. AIM: To translate the Qualiveen, to adapt it crossculturally, and to validate it for Portuguese. METHODS: Fifty-one patients with spinal cord injury (SCI), multiple sclerosis (MS), and myelomeningocele (MMC) completed both Qualiveen and the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) twice, at an mean interval of 15.5 days. RESULTS: A reliability study revealed internal consistency (Cronbach's alpha coefficients 0.75-0.90 for all four domains). Test-retest reliability demonstrated moderate to strong stability (intraclass correlation coefficient range from 0.62 to 0.86). Construct validity was assessed using the Qualiveen's scores and ICIQ-SF final score. It was significant for the majority of Qualiveen's score domains compared with the ICIQ-SF final score. CONCLUSION: The Portuguese version of the Qualiveen was successfully adapted and validated. It can be used for evaluation of general and urinary QoL in neurological patients.
Authors: José Tadeu Nunes Tamanini; Miriam Dambros; Carlos Arturo Levi D'Ancona; Paulo César Rodrigues Palma; Nelson Rodrigues Netto Journal: Rev Saude Publica Date: 2004-07-08 Impact factor: 2.106
Authors: Jose T N Tamanini; Miriam Dambros; Carlos A L D'Ancona; Paulo C R Palma; Neury J Botega; Luis A S Rios; Cristiano M Gomes; Fabio Baracat; Carlos A Bezerra; Nelson R Netto Journal: Int Braz J Urol Date: 2004 Nov-Dec Impact factor: 1.541
Authors: Véronique Bonniaud; Dianne Jackowski; Bernard Parratte; Rick Paulseth; Sharon Grad; Peter Margetts; Gordon Guyatt Journal: Qual Life Res Date: 2005-03 Impact factor: 4.147
Authors: P Costa; B Perrouin-Verbe; A Colvez; J Didier; P Marquis; A Marrel; G Amarenco; B Espirac; A Leriche Journal: Eur Urol Date: 2001-01 Impact factor: 20.096
Authors: Denise G Tate; Tracey Wheeler; Giulia I Lane; Martin Forchheimer; Kim D Anderson; Fin Biering-Sorensen; Anne P Cameron; Bruno Gallo Santacruz; Lyn B Jakeman; Michael J Kennelly; Steve Kirshblum; Andrei Krassioukov; Klaus Krogh; M J Mulcahey; Vanessa K Noonan; Gianna M Rodriguez; Ann M Spungen; David Tulsky; Marcel W Post Journal: J Spinal Cord Med Date: 2020-03 Impact factor: 1.985
Authors: Daniel Xavier Lima; Cleidismar Rosa Pires; Ana Clara Rezende Dos Santos; Raphaela Gomes Mendes; Carlos Eduardo Corradi Fonseca; Orlando Barreto Zocratto Journal: Int Braz J Urol Date: 2015 May-Jun Impact factor: 1.541
Authors: Sarah H M Reuvers; Ida J Korfage; Jeroen R Scheepe; Lisette A 't Hoen; Tebbe A R Sluis; Bertil F M Blok Journal: BMC Urol Date: 2017-09-19 Impact factor: 2.264